Air Liquide strengthens its Home Healthcare activity with an acquisition in Belgium and the Netherlands

Air Liquide is continuing its development with the acquisition of Homecare activities in Belgium and the Netherlands. With this operation, the Group broadens its presence and offer in these countries. Worldwide Air Liquide already supports 2 million people at home living with a chronic disease and has made Home Healthcare activities one of its strategic development priorities.

The two entities acquired in Belgium and the Netherlands support 10,000 patients living with respiratory insufficiency, sleep apnea syndrome or requiring infusion or nutrition treatments. With a turnover of more than €10 million in 2023, they are supported by around fifty employees who have joined the Air Liquide Group.

VitalAire, Air Liquide’s international Home Healthcare brand, is already present in Belgium, Luxembourg and the Netherlands. Drawing on its medico-technical expertise, its experience in personalized support for patients and in the development of associated digital services, Air Liquide, through this acquisition, is strengthening its presence and completing its infusion offer in these two countries.

The geographic and therapeutic complementarity of the acquired entities, combined with the professionalism and the operational excellence of the Air Liquide Group’s teams, will facilitate the development of care plans adapted to patients’ needs and profiles.

Diana Schillag, member of Air Liquide’s Executive Committee in charge of Healthcare, Sustainable Development and Procurement, stated:

“We are delighted to strengthen our position in those growing markets and to welcome these new patients and employees to Air Liquide. As a major player in Home Healthcare throughout the world, our ambition is to improve the quality of life of patients to best meet their needs at the lowest cost to society, thereby contributing to more efficient and sustainable healthcare systems.”

Air Liquide Healthcare is a world leader in medical gases, home healthcare services and specialty ingredients. Our 16,500 employees support 2 million chronic patients and provide medical gases and related services to 20,000 hospitals and new care facilities, as well as 140,000 healthcare professionals. Committed to working alongside professionals and health institutions, our patient-centered approach is based on the principles of Value-based Healthcare, which aims to improve the benefits experienced by patients, at the best cost to society, thus contributing to a more efficient and virtuous system.